<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate the antitumor activities and safety of Ad-KDRscFv, Ad-sTRAIL (114-281) and Ad-KDRscFv:sTRAIL in vivo and in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Recombinant replication-defective adenovirus vectors encoding either the extracellular domain (114-281 aa) of TRAIL, the KDRscFv (single chain antibody (scFv) against human vascular endothelial growth factor (VEGF) receptor KDR) or the fusion gene of KDRscFv:sTRAIL were constructed and transfected into HEK 293 cells for virus packaging </plain></SENT>
<SENT sid="2" pm="."><plain>The recombinant virus particles were then infected human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines of <z:hpo ids='HP_0002896'>liver cancer</z:hpo> (HepG2), <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> (SGC-7901), <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (SW480) and <z:mpath ids='MPATH_458'>normal</z:mpath> human liver cell line (LO2) to investigate the antitumor activities </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0003815'>Nude</z:mp> mice of the subcutaneous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> models were established with HepG2 cells and were randomly divided into different groups to investigate the therapeutic effect and safety of these adenovirus particles on <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of foreign proteins and the effect on microvascular number were also evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> three adenovirus particles could induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells lines HepG2, SGC-7901 and SW480, but had no obvious lethal effect on LO2 cells </plain></SENT>
<SENT sid="6" pm="."><plain>Ad-KDRscFv:sTRAIL showed the strongest tumoricidal effect </plain></SENT>
<SENT sid="7" pm="."><plain>After intratumoral injection with these adenovirus particles on <z:mp ids='MP_0003815'>nude</z:mp> mice model, <z:hpo ids='HP_0000001'>all</z:hpo> the three adenoviruses could inhibit the <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and the expression of foreign proteins (sTRAIL, KDRscFv and KDRscFv:sTRAIL fusion protein) was restricted to liver and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues </plain></SENT>
<SENT sid="8" pm="."><plain>In coincidence with the result in vitro, Ad-KDRscFv:sTRAIL also had the strongest antitumor activity in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>No obvious pathological changes were detected in vivo </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Replication-defective recombinant adenovirus of Ad-KDRscFv, Ad-sTRAIL and Ad-KDRscFv:sTRAIL <z:hpo ids='HP_0000001'>all</z:hpo> had tumoricidal activities and Ad-KDRscFv:sTRAIL showed the strongest effect </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three adenoviruses had no obvious toxicity to <z:mpath ids='MPATH_458'>normal</z:mpath> cells and tissues in vitro and in vivo </plain></SENT>
</text></document>